Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099827 · ClinicalTrials.gov registry record · Phase 1
Teen Depression Awareness Project (TDAP)
A Phase 1 study of Depression, sponsored by RAND.
- Completed
- Registry status
- Phase 1
- Development phase
- 368
- Enrollment target
- 8
- Study locations
NCT00099827 is a Phase 1 study of Depression that has completed, run by RAND. The registered enrollment target is 368 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (53% lower). The trial reports 8 study locations across 3 states.
The verdict
NCT00099827, a Phase 1 study of Depression, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 368 participants
- Enrollment target
- 8
- Study locations
Study Summary
The main objective of this research project is to describe the impact of depression on adolescent and family functioning compared to that of healthy adolescents and to understand the impact of Feedback and Patient Activation (FPA) on teen and family decision-making regarding seeking care for depressive disorders.
Conditions Studied
Interventions
- BEHAVIORAL Education
Study Locations (8)
Maryland
- Capital Medical Group - Chevy Chase
- Kaiser Mid-Atlantic - Kensington
- Kaiser Mid-Atlantic - Rockville
- Kaiser Mid-Atlantic-Camp Springs - Temple Hills
California
- Family Care Specialists at White Memorial Medical Center - Los Angeles
- Northeast Valley Health Corporation-San Fernando Valley High School - San Fernando
District of Columbia
- Children's National Medical Center Adolescent Health Clinic - Washington D.C.
- Children's Pediatricians and Associates - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2003-10 |
| Est. Completion | 2006-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00099827
The ClinicalTrials.gov registry entry for NCT00099827 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (53% lower). The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Education is the first listed.
NCT00099827 reports 8 study locations spanning 3 distinct geographic areas - top geographies include Maryland, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00099827 about?
NCT00099827 is a clinical study titled "Teen Depression Awareness Project (TDAP)". The main objective of this research project is to describe the impact of depression on adolescent and family functioning compared to that of healthy adolescents and to understand the impact of Feedback and Patient Activation (FPA) on teen and family decision-making regarding seeking care for depress...
What is the current status of trial NCT00099827?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 368 participants. The study started on 2003-10. Estimated completion is 2006-09.
What conditions does trial NCT00099827 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00099827?
The interventions under investigation include: Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00099827?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00099827 being conducted?
This trial has 8 study locations across California, District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans
RECRUITING · Phase 1
-
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
RECRUITING · Phase 1
-
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.